ITUB20160416A1 - Use of a slow-release formulation of octreotide for the prevention of seroma formation - Google Patents

Use of a slow-release formulation of octreotide for the prevention of seroma formation

Info

Publication number
ITUB20160416A1
ITUB20160416A1 ITUB2016A000416A ITUB20160416A ITUB20160416A1 IT UB20160416 A1 ITUB20160416 A1 IT UB20160416A1 IT UB2016A000416 A ITUB2016A000416 A IT UB2016A000416A IT UB20160416 A ITUB20160416 A IT UB20160416A IT UB20160416 A1 ITUB20160416 A1 IT UB20160416A1
Authority
IT
Italy
Prior art keywords
octreotide
prevention
slow
release formulation
seroma formation
Prior art date
Application number
ITUB2016A000416A
Other languages
Italian (it)
Inventor
Paolo Bettica
Carlo Bianchini
Sara Manzoni
Giuseppe Colombo
Paolo Mascagni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Priority to ITUB2016A000416A priority Critical patent/ITUB20160416A1/en
Publication of ITUB20160416A1 publication Critical patent/ITUB20160416A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
ITUB2016A000416A 2016-01-28 2016-01-28 Use of a slow-release formulation of octreotide for the prevention of seroma formation ITUB20160416A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUB2016A000416A ITUB20160416A1 (en) 2016-01-28 2016-01-28 Use of a slow-release formulation of octreotide for the prevention of seroma formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000416A ITUB20160416A1 (en) 2016-01-28 2016-01-28 Use of a slow-release formulation of octreotide for the prevention of seroma formation

Publications (1)

Publication Number Publication Date
ITUB20160416A1 true ITUB20160416A1 (en) 2017-07-28

Family

ID=55861012

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2016A000416A ITUB20160416A1 (en) 2016-01-28 2016-01-28 Use of a slow-release formulation of octreotide for the prevention of seroma formation

Country Status (1)

Country Link
IT (1) ITUB20160416A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787658A1 (en) * 2005-11-10 2007-05-23 South Shore Properties Inc. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
WO2013083459A1 (en) * 2011-12-05 2013-06-13 Camurus Ab Robust controlled-release peptide formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787658A1 (en) * 2005-11-10 2007-05-23 South Shore Properties Inc. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
WO2013083459A1 (en) * 2011-12-05 2013-06-13 Camurus Ab Robust controlled-release peptide formulations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PAOLO CARCOFORO ET AL: "Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial", JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS., vol. 196, no. 3, 1 March 2003 (2003-03-01), US, pages 365 - 369, XP055290827, ISSN: 1072-7515, DOI: 10.1016/S1072-7515(02)01757-X *
S A MAHMOUD ET AL: "LETTER TO THE EDITOR Octreotide Can Control Lymphorrhea after Axillary Node Dissection in Mastectomy Operations", BREAST JOURNAL, vol. 13, no. 1, 1 January 2007 (2007-01-01), US, pages 108 - 109, XP055290848, ISSN: 1075-122X, DOI: 10.1111/j.1524-4741.2006.00380 *

Similar Documents

Publication Publication Date Title
DK3464271T3 (en) PYRAZOLD DERIVATIVES AS PLASMA CALLICREIN INHIBITORS
DK3381918T3 (en) 7- (Thiazol-5-yl) -pyrrolopyrimidine compound as TLR7 agonist
BR112016015706A2 (en) compound, use of it and pharmaceutical composition
EP3208898A4 (en) Semiconductor laser oscillator
DK3533796T3 (en) AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS NEUTROF FACTOR TYROSINKINASE RECEPTOR INHIBITOR
DK3380059T3 (en) SPRAY THE FILLING ADAPTER
DK3271349T3 (en) BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
DK3538528T3 (en) PYRROLAMIDES LIKE ALPHA V INTEGRINE INHIBITORS
EP3276759A4 (en) Semiconductor laser oscillator
BR112017004451A2 (en) stone paint formulation and methods to produce the same
BR112016026046A2 (en) Use of Thienotriazolodiazepine Compounds
DK3153508T3 (en) NAPHTHOFURAND DERIVATIVES FOR USE AS ANTICANCER AGENTS
KR20180084960A (en) Dental tools
EP3130592A4 (en) Analogues of 4h-pyrazolo[1,5- ]benzimidazole compound as parp inhibitors
ZA201704462B (en) New benzimidazole derivatives as antihistamine agents
MA54257A (en) PLASTERBOARD
FR3026399B1 (en) CRANE, INCLUDING CRANE-DERRICK
SMT201600429B (en) ASSEMBLY ASSEMBLY OF A RAILING
ZA201606653B (en) Solid forms of a pharmaceutically active compound
ITBA20140018A1 (en) MACHINERY FOR THE PRODUCTION OF STRACCIATELLA
DK3484875T3 (en) Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
ITUA20161928A1 (en) HYDRAULIC PUMPING DEVICE FOR SALTUARY USE
ITUB20153586A1 (en) MODULAR GROUP FOR THE FORMATION OF CONSTRUCTION FOR LUDIC USE.
ITUB20160416A1 (en) Use of a slow-release formulation of octreotide for the prevention of seroma formation
ITUA20162588A1 (en) Use of a composition comprising alpha-lipoic acid.